Sun Pharma, Mylan face price fixing charges in US

Suit also filed against Sandoz and Mylan for colluding to hike price of another respiratory drug

Veena Mani  |  New Delhi 

A New York grocery workers' union filed a class action suit in a Pennsylvania federal court last week against Sun Pharamceutical Industries in the US for colluding with Mylan for conspiring to raise the price of generic asthma medicine (albuterol sulfate tablets). The same union also filed another suit for similar charges against Mylan and Sandoz for colluding to boost the cost of another generic asthma medicine (Benazepril HCTZ). The complaint stated that Sun Pharmaceuticals and Mylan had raised their prices for albuterol sulfate over 3,000 per cent between October 2013 and April ...

TO READ THE FULL STORY, SUBSCRIBE NOW AT JUST Rs 149 A MONTH

Key stories on business-standard.com are available to premium subscribers only.

LOGIN

EMAIL / USER NAME
PASSWORD
REMEMBER ME Forgot password?
LOGIN

Not a member yet ? Resister Now

Connect using any below

  • Don't lose the opportunity of saving $26.77 per month
  • Don't lose the opportunity of saving $26.77 per month
Total Amount
Rs. 0.00
To proceed, kindly select a subscription package

WHAT YOU GET

On Business Standard Digital

  • Access your subscription from anywhere. Be it your computer, tablet or smartphone using a browser or the App, Your Choice.
  • Access to exclusive content, features, opinions and comment, hand-picked by our editors, just for you.
  • Pick your 5 favourite companies. Get all the news upates at the end of each day through E-Mail.
  • Pick the industry that you want to track. And get a daily news letter specific to that industry. Cut out the clutter.
  • And stay on top of your investments. Track stock prices in your portfolio
  • Access 18 years of archival data

On Digital

  • Seamless access to WSJ.com with your Business Standard digital account.
  • Experience the best of the Journal's reporting, video and interactive features.
  • Read about the people and events shaping business, finance, technology, politics, technology and culture.
  • Stay informed with newsletters - an easy way to get WSJ content straight to your inbox - making life easier on your busiest days.
  • More business executives read the Journal globally than any other publication.
*Note :
Our Partners are proud to be associated with this initiative and will contribute Rs 100 x 6 months thereafter, standard rate of Rs 149 will be charged.
Offer valid for Indian residents only
Requires you to share personal information like PAN, Date of Birth, and Income.
*Annual saving on WSJ subscription price of US$ 347.88 (12 months @ US$ 28.99 per month)
* 1US$ = 67.50 INR.
*Please note that this offer is not valid if you are/were a registered/existing user on WSJ Digital

Sun Pharma, Mylan face price fixing charges in US

Suit also filed against Sandoz and Mylan for colluding to hike price of another respiratory drug

A class action suit has been filed against Inda-based Sun Pharmaceutical and US-based Mylan in a district court in Pennsylvania, America. Filed last week, it accuses the two companies of colluding to raise the price of albuterol sulfate tablets. Albuterol is a bronchodilator, used by patients suffering from wheezing. The suit has been filed by the United Food and Commercial Workers local unit (Local 1500); the union is the largest in New York. The suit is also against Sandoz, with the union alleging Mylan and Sandoz colluded to increase the price of Benazepril, another drug for a respiratory ailment. The allegation against Sun is that Mylan and it had raised their prices for albuterol sulfate by over 3,000 per cent between October 2013 and April 2014. Business Standard has a copy of the complaint. It reads, "Beginningin May 2013, defendants caused the price of albuterol sulfate to dramatically increase in unison. The increases were the result of an agreement among them to increase ... A New York grocery workers' union filed a class action suit in a Pennsylvania federal court last week against Sun Pharamceutical Industries in the US for colluding with Mylan for conspiring to raise the price of generic asthma medicine (albuterol sulfate tablets). The same union also filed another suit for similar charges against Mylan and Sandoz for colluding to boost the cost of another generic asthma medicine (Benazepril HCTZ). The complaint stated that Sun Pharmaceuticals and Mylan had raised their prices for albuterol sulfate over 3,000 per cent between October 2013 and April ... image
Business Standard
177 22